Raymond James & Associates’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-11,696
Closed -$238K 3850
2023
Q3
$238K Sell
11,696
-379
-3% -$9.53K ﹤0.01% 3362
2023
Q2
$353K Sell
12,075
-1,789
-13% -$49K ﹤0.01% 3142
2023
Q1
$389K Sell
13,864
-4,236
-23% -$109K ﹤0.01% 3064
2022
Q4
$335K Sell
18,100
-7,084
-28% -$121K ﹤0.01% 3148
2022
Q3
$397K Sell
25,184
-128,404
-84% -$2.88M ﹤0.01% 2999
2022
Q2
$3.88M Buy
153,588
+545
+0.4% +$16.3K ﹤0.01% 1570
2022
Q1
$5.53M Sell
153,043
-109,174
-42% -$5.38M ﹤0.01% 1441
2021
Q4
$20.1M Sell
262,217
-16,358
-6% -$1.44M 0.02% 741
2021
Q3
$26.8M Sell
278,575
-1,576
-0.6% -$172K 0.02% 566
2021
Q2
$29.9M Buy
280,151
+1,684
+0.6% +$166K 0.03% 524
2021
Q1
$24.9M Buy
278,467
+3,168
+1% +$349K 0.03% 565
2020
Q4
$27.7M Buy
275,299
+13,992
+5% +$1.04M 0.03% 481
2020
Q3
$12.8M Buy
261,307
+13,576
+5% +$652K 0.02% 738
2020
Q2
$10.1M Sell
247,731
-25,615
-9% -$736K 0.01% 827
2020
Q1
$4.21M Sell
273,346
-162,024
-37% -$3.41M 0.01% 1138
2019
Q4
$9.85M Buy
+435,370
New +$7.14M 0.01% 908

Other funds holding CRNC

Raymond James & Associates's CRNC Position: Q4 2023 in Review

Raymond James & Associates sold out of Cerence (CRNC) in Q4 2023, closing a stake of 11,696 shares — an estimated $238K sold.

Raymond James & Associates first reported a position in CRNC in Q4 2019 and held it in 16 quarters. The position peaked at $29.9M in Q2 2021. 217 funds tracked by Wall St. Rank hold CRNC as of Q4 2023.

  • Raymond James & Associates reported no remaining Cerence position as of Q4 2023 after selling out during the quarter.
  • Raymond James & Associates sold 11,696 Cerence shares in Q4 2023, an estimated $238K.
  • Raymond James & Associates first reported a position in Cerence in Q4 2019 and held it in 16 quarters.
  • Raymond James & Associates's Cerence position peaked at $29.9M in Q2 2021.
  • 217 funds tracked by Wall St. Rank held Cerence as of Q4 2023.

Based on Raymond James & Associates's 13F filing for Q4 2023, filed 16 Jan 2024.